PTGS2 and cancer: Since COX-2 and prostaglandin-2 are involved in the inflammatory response, the suppression of apoptosis, and the formation of drug resistance, the inhibition of COX-2 can reduce inflammation and, as a result, reduce the rate of metastasis of malignant neoplasms [15].